Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company’s web site at www.depomedinc.com.
- 17 years ago
QualityStocks
Depomed, Inc. (NASDAQ: DEPO)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) was awarded an additional $18.4 million funding from the…
-
QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) CEO Shares Bold Strategy on Exploring Mining Podcast
ESGold (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) was recently featured on the Exploring Mining podcast, where new CEO…
-
QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Advances Integrated Approach in Broader Growth Strategy
Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) recently took a significant step in fostering industry collaboration and…